Basic Information
ID: ALA3592354
Type: ADME
Description: Drug formation in female mouse brain treated with 0.53 mg/kg, iv (3S,6S,9S,12S,15S,18S,21R,23S,24S,27S,30S,33S)-33-acetamido-15-benzyl-3-carbamoyl-6-(2-carboxyethyl)-27-(carboxymethyl)-23-hydroxy-12-(4-hydroxybenzyl)-24,30-diisobutyl-18-isopropyl-9,21-dimethyl-5,8,11,14,17,20,26,29,32-nonaoxo-4,7,10,13,16,19,25,28,31-nonaazahexatriacontane-1,36-dioic acid measured up to 2 hrs by HPLC-FLU/LC-MS analysis
Organism: Mus musculus
Tissue: Brain
Activity Charts
Bioactivity
Activity Types for Assay ALA3592354
Drug metabolism
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 1285.41 |